In a longstanding and complicated legal battle between Apple and Masimo, a recent ruling from a California jury may be the first step towards a certain conclusion. As reported by Reuters, a federal jury sided with Masimo, a medical tech company known for its patient monitoring devices, when it said that Apple infringed on the company’s patent for technology that tracks blood-oxygen levels.
The case revolves around whether Apple violated Masimo’s patent related to blood-oxygen sensors, which the jury claimed can be seen with the Apple Watch’s Workout and Heart Rate apps. According to Reuters, Apple
→ Continue reading at Engadget
